A. de Stefani

Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.

E. Galeazzi, M. Olivero, F. Gervasio, A. de Stefani +4 more

1997European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery42 citations

Semantic Scholar

A. de Stefani

Most-cited papers

Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin‐2 injected periiymphatically

Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases

Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx

Interleukin‐2 injected around tumor‐draining lymph nodes in head and neck cancer

Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically.

Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.

Prognostic Factors of Cervical Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma

Treatment of oral cavity and oropharynx squamous cell carcinoma with perilymphatic interleukin-2: clinical and pathologic correlations.

Tumor immunotherapy by local injection of interleukin 2 and non-reactive lymphocytes. Experimental and clinical results.

Prognostic factors for head and neck tumor recurrence.

Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinoma.

The effect of preoperative local interleukin-2 (IL-2) injections in patients with head and neck squamous cell carcinoma. An immunological study.

Detection ofMET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas

Squamous Cell Carcinoma of the Lacrimal Drainage System: Case Report and Literature Review

Infiltrating leukocyte populations and T-lymphocyte subsets in head and neck squamous cell carcinomas from patients receiving perilymphatic injections of recombinant interleukin 2. A pathologic and immunophenotypic study.

Basic science reviews: Immunomodulation therapy for squamous cell carcinoma of the head and neck

[Tumors of the parapharyngeal space: case report of clear cell myoepithelioma of the parotid gland and review of literature].

Immunology of head and neck cancer: perspectives.

Adjuvant Radiotherapy Influences the Survival of Patients with Squamous Carcinoma of the Head and Neck who Have Poor Prognoses

Carcinoma of the larynx in the elderly: Analysis of potentially significant prognostic variables

Current role of radiotherapy in the treatment of locally advanced laryngeal carcinomas

Perilymphatic injections of cytokines: a new tool in active cancer immunotherapy. Experimental rationale and clinical findings.

[Identification of clinical, biological and prognostic factors in recurring squamous cell carcinoma of the head and neck].

Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio‐chemotherapy

[Loco-regional treatment with low and high doses of interleukin-2 of head and neck squamous cell carcinoma recurrences].

[Recurrences of epithelial tumors of the head and neck: review of the literature and a critical analysis of the problem].

[Perilymphatic injection of interleukin-2 (IL-2) in recurrent squamous cell carcinoma of the head and neck].

Injections of Interleukins Around Tumor-Draining Lymph Nodes: A New Mode of Immunotherapy

Perspectives in Cancer Research Immunoprevention of Cancer : Is the Time Ripe ? 1

[Laryngeal myoblastoma in childhood].

[Chemotherapy of head and neck carcinomas].

Treatment of poor-prognosis head and neck cancer (HNC) with alpha-interferon (a-IFN) and concomitant radiotherapy

Interleukin-2 and head and neck squamous cell carcinoma: clinical and pathological studies.

LE RECIDIVE DEI TUMORI EPITELIALI DELLA TESTA E DEL COLLO: REVISIONE DELLA LETTERATURA ED ANALISI CRITICA DEL PROBLEMA

[Immunologic surveillance in human laryngeal carcinoma].